Q8(R2) (Step 4, 1 August 2009)
Pharmaceutical Development
ICHICH guidelineOtherDevices and medicinesHigh confidenceLast verified October 4, 2026
Gives guidance on what goes into section 3.2.P.2 (Pharmaceutical Development) of the quality module for drug products. It does not apply to submissions at the clinical research stages. An annex describes the principles of quality by design.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
| Market | Status | Edition accepted | National code | Details |
|---|
| United States | Adopted | - | Vol. 71, No. 98 | Effective November 1, 2009 |
| European Union | Adopted | - | CHMP/ICH/167068/2004 | Effective August 1, 2009 |
|
Related standards: Q5A(R2), Q5B, Q5D, Q5E, Q11, Q12, Q13, ISO/IEC 17050-1, AS/NZS 3551, UN Manual of Tests and Criteria, section 38.3. See all standards.
Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.